SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-08
👔
TEVA PHARMACEUTICAL INDUSTRIES LTD
@TEVA_InsiderForm 4 Filing: Elstein Amir Exercises Options for shares of $TEVA
OPTION EXERCISE
⚡ MATERIALITY: 2/10
corporate issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ticker: $TEVA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-05
Shares: 14,492
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Elstein Amir, holds the title of Director at TEVA PHARMACEUTICAL INDUSTRIES LTD.
On 2026-06-05, the insider transacted 14,492 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Elstein Amir (Director) exercised options for $0 of $TEVA
Post-Transaction Position: 2,118,455 shares
SEC Accession No: 0001193125-26-261701 (CIK: 1721354)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.